E
Inspira Technologies Oxy B.H.N. Ltd. IINN
$0.75 -$0.03-3.85% NASDAQ
Recommendation
Prev Close
$0.78
Volume
229,103
Avg Vol (90D)
200,325
Market Cap
$28.04M
Dividend & Yield
--
52-Week Range
$0.40 - $1.65
P/E (TTM)
--
EPS (TTM)
-$0.47
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
ART100 Becomes Inspira's First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center
1/29/2026 - Globe Newswire
Inspira Technologies Nears Final Government Approval for $49.5 Million in Purchase Orders
1/21/2026 - TipRanks Financial Blog
Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders
1/21/2026 - Globe Newswire
Inspira Technologies Oxy BHN Ltd trading resumes
1/13/2026 - TipRanks Financial Blog
Inspira Technologies Oxy BHN Ltd trading resumes
1/13/2026 - The Fly
Inspira Technologies Oxy BHN Ltd trading halted, news pending
1/13/2026 - TipRanks Financial Blog
Inspira Technologies Oxy BHN Ltd trading halted, news pending
1/13/2026 - The Fly
Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion
1/8/2026 - Globe Newswire
CORRECTION Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation
1/5/2026 - Globe Newswire
Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation
1/5/2026 - Globe Newswire
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones
12/23/2025 - Globe Newswire
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution
12/15/2025 - Globe Newswire
Inspira Technologies Secures Japanese Patent for Innovative Cannula Device
12/9/2025 - TipRanks Financial Blog
Inspira Technologies Granted Patent in Japan for the INSPIRA ART System's Convertible Dual Lumen Cannula Device and Method of Use
12/9/2025 - Globe Newswire
Inspira Technologies Announces Strategic Leap in Lab Capabilities Accelerating Next-Generation Diagnostics and Blood Technology
12/3/2025 - Globe Newswire
Inspira Completes Clinical Study for HYLA Blood Sensor - Ahead of Regulatory Submission
11/13/2025 - Globe Newswire
Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion
11/6/2025 - Globe Newswire
Inspira Technologies and Bites Forge AI Alliance to Enhance Global Medical Training
10/22/2025 - TipRanks Financial Blog
Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem
10/22/2025 - Globe Newswire
Inspira Technologies Strengthens Leadership with Key Appointments
10/21/2025 - TipRanks Financial Blog
Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm
10/21/2025 - Globe Newswire
Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm
10/21/2025 - Globe Newswire
Inspira Technologies Announces Major Milestones and Financial Results for First Half of 2025
10/1/2025 - TipRanks Financial Blog
Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update
10/1/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$289.00K
EBITDA (TTM)
-$12.52M
EBIT (TTM)
-$12.70M
Net Income (TTM)
-$11.21M
Balance Sheet
Total Assets (Q)
$4.45M
Total Debt (Q)
$640.00K
Total Liabilities (Q)
$3.17M
Book Value Per Share (Q)
$0.0446
Cash Flow
Cash from Operations (TTM)
-$9.60M
Cash from Investing (TTM)
$3.44M
Cash from Financing (TTM)
$4.67M
Net Change in Cash (TTM)
-$1.42M
Filings
Filing Date
Wednesday, October 1, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
1.73
7-Day Total Return
-4.15%
30-Day Total Return
-26.47%
60-Day Total Return
-15.57%
90-Day Total Return
-40.48%
Year to Date Total Return
-18.51%
1-Year Total Return
-21.05%
2-Year Total Return
-21.88%
3-Year Total Return
-53.68%
5-Year Total Return
--
52-week Low
May 28, 2025 - $0.40
52-week High
Jul 08, 2025 - $1.65
Valuation
Market Cap
$28.04M - Nano Cap
Enterprise Value
$26.55M
Price/Sales (TTM)
72.90
Price/Book (Q)
17.49
Dividends and Shares
Shares Outstanding
26.78M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
inspira-technologies.com
Phone Number
972 4 623 0333
Address
2 Ha-Tidhar St.
Ra'anana, 4366504
Country
Israel
Year Founded
2018
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the... more
NASDAQ 01/30/2026 4:00PM Eastern Quotes delayed